A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease.

Farlow MR, Thompson RE, Wei L-J, Tuchman AJ, Grenier E, Crockford D, Wilke S, Benison J, Alkon DL
J Alzheimers Dis. 2019; 67(2):555-570. PMID: 30530975. Abstract